Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 47.7% | 54.8% | (25.1%) | 51.2% | 50.2% | 50.3% | 49.8% | 45.2% | 41.3% | 40.4% | 61.3% | 68.0% | 58.0% | 54.1% | 37.1% | 19.1% | 28.5% | 27.1% | 26.9% | 28.0% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 29.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Gilead Sciences, Inc. have been 29.9% over the past three years, and 26.5% over the past five years.
As of today, Gilead Sciences, Inc.'s Operating Income margin is 29.6%, which is higher than industry median of 21.7%. It indicates that Gilead Sciences, Inc.'s Operating Income margin is Good.